Join the Head and Neck Cancer group to help and get support from people like you.
Head and Neck Cancer News (Page 2)
Related terms: Oral Cancer
American Academy of Otolaryngology-Head and Neck Surgery, Sept. 28-Oct. 1
The annual meeting of the American Academy of Otolaryngology-Head and Neck Surgery was held from Sept. 28 to Oct. 1 in Miami, drawing participants from around the world, including otolaryngologists,...
2023 Cisplatin Shortage Tied to Use of Alternatives for Head, Neck Cancer
TUESDAY, Oct. 1, 2024 – The 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a...
Certain Oral Bacteria Tied to Risk for New Head, Neck Squamous Cell Cancer
WEDNESDAY, Oct. 2, 2024 – Certain oral bacteria are a risk factor for development of head and neck squamous cell cancer (HNSCC), according to a study published online Sept. 26 in JAMA Oncology. ...
Gum Disease Germs Could Help Trigger Cancer
THURSDAY, Sept. 26, 2024 – Bacteria that causes gum disease can also raise a person’s risk of head and neck cancers, a new study says. More than a dozen bacterial species have been linked to a c...
Neoadjuvant Chemo Boosts Structure Preservation Rates in Nasal, Sinus Cancer
WEDNESDAY, Sept. 18, 2024 – Neoadjuvant platinum-based chemotherapy improves structure preservation (SP) for patients with T3, T4a, and selected T4b resectable nasal and paranasal sinus squamous...
Salivary CD44, Total Protein ID Recurrence Risk in Head and Neck Cancer
THURSDAY, Aug. 22, 2024 – Elevated salivary levels of CD44 and total protein (TP) can identify head and neck cancer patients with an increased risk for cancer recurrence, according to a study...
Cannabis-Related Disorder Linked to Risk for Head and Neck Cancer
MONDAY, Aug. 12, 2024 – Cannabis-related disorder is associated with an increased rate of head and neck cancer (HNC), according to a study published online Aug. 8 in JAMA Otolaryngology-Head & Neck...
Heavy Marijuana Use More Than Triples Odds for Head & Neck Cancers
THURSDAY, Aug. 8, 2024 – People who use marijuana at high levels are putting themselves at more than three times the risk for head and neck cancers, new research warns. The study is perhaps the most...
Higher Mortality, Less Improvement Seen for Rural Residents With Head, Neck Cancer
THURSDAY, July 11, 2024 – Compared with their urban counterparts, rural residents with head and neck cancer (HNC) have higher mortality rates and less annual improvement, according to a research...
Doctors Perform Larynx Transplant in Cancer Patient
WEDNESDAY, July 10, 2024 – For years, Marty Kedian had been without a voice. Kedian, who hails from Haverhill, Mass., has undergone dozens of surgeries while being treated for a rare form of...
Survey Shows Men Need to Do More to Prevent Cancer
FRIDAY, July 5, 2024 – American men are blowing their best chance to head off cancer or spot it early, when it's easiest to treat, a new survey warns. More than 6 in 10 (65%) men in the nationwide...
FDA Approves Merck’s Gardasil 9 for the Prevention of Certain HPV-Related Head and Neck Cancers
KENILWORTH, N.J.--(BUSINESS WIRE) June 12, 2020 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved...
FDA Approves Keytruda (pembrolizumab) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma
KENILWORTH, N.J.--(BUSINESS WIRE) June 11, 2019 --Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved...
Bristol-Myers Squibb’s Opdivo (nivolumab) Now the First and Only FDA-Approved PD-1 Inhibitor to Offer Every Four-Week Dosing
PRINCETON, N.J.--(BUSINESS WIRE) March 6, 2018 --Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License...
Bristol-Myers Squibb’s Opdivo (nivolumab) is the First Immuno-Oncology Treatment to Receive FDA Approval Based on Overall Survival in Head and Neck Cancer
PRINCETON, N.J.--(BUSINESS WIRE) November 10, 2016 --Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab)...